Federal Awards · EXELAN PHARMACEUTICALS INC · Award

NEW AWARD FOR LISINOPRIL TABLETS WITH EXELAN. PERIOD OF PERFORMANCE IS FEB 12, 2022 TO FEB 11, 2023 WITH FO…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID: 36E79722D0005
Contractor: EXELAN PHARMACEUTICALS INC
Awarding agency: Department of Veterans Affairs
Sub-agency / office: Department of Veterans Affairs
Award amount: $0
Period of performance: Feb 12, 2022 – —
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
PSC: PSC 6505
Competition: FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 3 offers
Pricing: FIRM FIXED PRICE
Financial breakdown: Obligated $0 · Potential value $40,480,225 · Latest action obligation $0

Public award description

NEW AWARD FOR LISINOPRIL TABLETS WITH EXELAN. PERIOD OF PERFORMANCE IS FEB 12, 2022 TO FEB 11, 2023 WITH FOUR ONE-YEAR OPTIONS.

Most recent · Modification P00021 · Sep 2, 2026 · $0 action obligation · IMPLEMENTATION OF EXECUTIVE ORDER 14398 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS · 36E79722D0005

Modification P00020 · Mar 18, 2026 · $0 action obligation · INCORPORATE 2026/2027 SUBCONTRACTING PLAN · 36E79722D0005

Modification P00019 · Jan 9, 2026 · $0 action obligation · EXERCISE OPTION YEAR 4 EFFECTIVE FEB 12, 2026 TO FEB 11, 2027 FOR LISINOPRIL TABLETS WITH EXELAN · 36E79722D0005

Modification P00018 · Apr 14, 2025 · $0 action obligation · INCORPORATE SUBK PLAN 4/1/2025 - 3/31/2026 · 36E79722D0005

Modification P00017 · Jan 13, 2025 · $0 action obligation · THIS MODIFICATION IS TO EXERCISE OPTION YEAR 3 CONTRACT FEBRUARY 12, 2025, TO FEBRUARY 11, 2026 ON CONTRACT 36E79722D0005 FOR LISINOPRIL TABLETS. · 36E79722D0005

Modification P00016 · Sep 5, 2024 · $0 action obligation · THIS MODIFICATION IS ISSUED TO INCORPORATE 2 NDCS CHANGES UNDER CONTRACT 36E79722D0005, LISINOPRIL TABLETS. · 36E79722D0005

Modification P00015 · Apr 23, 2024 · $0 action obligation · ADMINISTRATIVE POINT OF CONTACT (POC) CHANGE · 36E79722D0005

Modification P00014 · Mar 25, 2024 · $0 action obligation · THIS MODIFICATION IS ISSUED TO INCORPORATE THE APPROVED COMMERCIAL COMPANY-WIDE SUBCONTRACTING PLAN INTO CONTRACT 36E79722D0005 FOR THE PERIOD OF 04/01/2024 - 03/31/2025. EXELAN PHARMACEUTICALS, INC. LISINOPRIL TABLETS · 36E79722D0005

Modification P00012 · Feb 8, 2024 · $0 action obligation · 52.212-4(C) CONTRACT TERMS AND CONDITIONS - CHANGES UPDATE TO COST RECOVERY FEE (CRF) AND SUBMISSION OF QUARTERLY SALES REPORTS FOR 36E79722D0005 EXELAN PHARMACEUTICALS, INC. LISINOPRIL TABLETS · 36E79722D0005

Modification P00011 · Jan 16, 2024 · $0 action obligation · POC ADMINISTRATIVE CHANGE TO BRIAN CHRISTENSEN · 36E79722D0005

Modification P00010 · Dec 29, 2023 · $0 action obligation · THIS MODIFICATION IS ISSUED TO EXERCISE THE 2ND OPTION YEAR FOR LISINOPRIL TABLETS UNDER CONTRACT 36E79722D0005 WITH EXELAN PHARMACEUTICALS, INC. FOR THE PERIOD OF 02/12/2024 - 02/11/2025. PRICES REMAIN THE SAME. · 36E79722D0005

Modification P00009 · Dec 21, 2023 · $0 action obligation · THIS MODIFICATION IS ISSUED TO DELETE 22 NDCS FROM CONTRACT 36E79722D0005, LISINOPRIL TABLETS. · 36E79722D0005

Modification P00008 · Sep 26, 2023 · $0 action obligation · POC ADMINISTRATIVE CHANGE FOR 36E79722D0005. · 36E79722D0005

Modification P00007 · Aug 24, 2023 · $0 action obligation · LISINOPRIL NDC CHANGES ON CONTRACT 36E79722D0005. OLD NDCS WILL REMAIN ON CONTRACT UNTIL FULLY DEPLETED. · 36E79722D0005

Modification P00006 · Jul 20, 2023 · $0 action obligation · ON CONTRACT 36E79722D0005, NDC CHANGES FOR FOURTEEN LISINOPRIL NDCS. OLD NDCS WILL REMAIN ON CONTRACT UNTIL FULLY DEPLETED. · 36E79722D0005

Modification P00005 · Jun 27, 2023 · $0 action obligation · INCORPORATE CONTRACT ADMINISTRATOR CHANGES TO CONTRACT 36E79722D0005. · 36E79722D0005

Modification P00004 · Apr 24, 2023 · $0 action obligation · INCORPORATION OF DRUG SUPPLY CHAIN SECURITY ACT (DSCSA) LANGUAGE · 36E79722D0005

Modification P00003 · Mar 28, 2023 · $0 action obligation · THIS MODIFICATION IS ISSUED TO INCORPORATE THE APPROVED COMMERCIAL COMPANY-WIDE SUBCONTRACTING PLAN INTO EXELAN CONTRACT 36E79722D0005 FOR THE PERIOD OF 04/01/2023 - 03/31/2024. · 36E79722D0005

Modification P00002 · Dec 27, 2022 · $0 action obligation · EXERCISE OPTION YEAR 1 EFFECTIVE FEBRUARY 12, 2023 THROUGH FEBRUARY 11, 2024 FOR LISINOPRIL TABLETS WITH EXELAN PHARMACEUTICALS, INC. PRICES REMAIN UNCHANGED. · 36E79722D0005

Modification P00001 · Feb 16, 2022 · $0 action obligation · EXELAN PHARMACEUTICALS, INC. 2022 SUBCONTRACTING PLAN. THIS MODIFICATION IS ISSUED TO INCORPORATE THE APPROVED COMMERCIAL COMPANY-WIDE SUBCONTRACTING PLAN INTO THE ABOVE REFERENCED CONTRACT FOR THE PERIOD OF 04/01/2022 - 03/31/2023 · 36E79722D0005

Modification 0 · Dec 14, 2021 · $0 action obligation · NEW AWARD FOR LISINOPRIL TABLETS WITH EXELAN. PERIOD OF PERFORMANCE IS FEB 12, 2022 TO FEB 11, 2023 WITH FOUR ONE-YEAR OPTIONS. · 36E79722D0005

Source: USAspending.gov

Related intelligence

Related Federal Awards

Same agency and NAICS · 36C24026K1010 — EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY · MCKESSON CORPORATION · Department of Veterans Affairs · $1,194,619,137
Same agency and NAICS · 36C25926F0310 — EMERGENCY PHARMACY CARVYKTI FOR RMR · JANSSEN BIOTECH INC · Department of Veterans Affairs · $384,719
Same agency and NAICS · 36C26226N0738 — Federal award — Department of Veterans Affairs · BRISTOL-MYERS SQUIBB COMPANY · Department of Veterans Affairs · $364,139
Same agency and NAICS · 36C24626P0824 — OMINCELL IVX WORKFLOW MANAGEMENT (4 DEVICES), IVX LABEL SFW, IVX COLOR PRINTER, IVX ZEBRA BARCODE SCANNER, · TRILLAMED LLC · Department of Veterans Affairs · $268,200
Same agency and NAICS · 36C77026N0048 — Federal award — Department of Veterans Affairs · MERZ PHARMACEUTICALS, LLC · Department of Veterans Affairs · $236,612
Same agency and NAICS · 36C24626N1034 — Federal award — Department of Veterans Affairs · PARTNER THERAPEUTICS, INC. · Department of Veterans Affairs · $72,362

Browse federal awards · Browse contractors